Medicine and Dentistry
Endometrial Cancer
100%
Hysterectomy
88%
Postoperative Pain
56%
Krukenberg Tumor
48%
Cervical Intraepithelial Neoplasia
48%
Cervical Cancer
41%
Positron Emission Tomography-Computed Tomography
37%
BRCA1
30%
Recurrent Disease
29%
Preoperative Evaluation
24%
Adenocarcinoma in Situ
24%
Observational Study
21%
Poly ADP Ribose Polymerase
20%
Neoplasm
19%
Lymph Node Metastasis
19%
Recurrence Risk
18%
Overall Survival
18%
Retrospective Study
18%
Uterine Cervix Conization
17%
CA-125
16%
Minimally Invasive Surgery
16%
Ovarian Cyst
16%
Magnetic Resonance Imaging
16%
Retroperitoneal Lymph Node Dissection
16%
Cancer Treatment
16%
Fistula
16%
Uterine Fibroid
16%
Skin Fistula
16%
Quantitative Sensory Testing
16%
Human Epididymis Protein 4
16%
Laparoscopy
16%
Granulosa Cell Tumour
16%
Chronic Pain
16%
Cytotechnology
16%
Wart Virus
16%
Cross Sectional Study
16%
Uterine Cervix
16%
Ovarian Cancer
16%
Homologous Recombination
16%
Long Term Survival
16%
Neoadjuvant Chemotherapy
16%
Screening
13%
Female Genital Tract Cancer
13%
Surgical Technique
11%
Prevalence
11%
Conservative Treatment
10%
Angioleiomyoma
10%
Pelvic Pain
10%
Surgery
9%
Salpingooophorectomy
9%
Keyphrases
Robot-assisted Laparoscopic Hysterectomy
48%
Endometrial Cancer
48%
Acute Postoperative Pain
32%
Cervical Intraepithelial Neoplasia
16%
Follow-up Adherence
16%
Evolutionary Rate Variation
16%
RNA Secondary Structure Prediction
16%
PET-MRI
16%
Epithelial Ovarian Cancer
16%
Prospective Comparative Study
16%
Preoperative Staging
16%
Lymphadenectomy
16%
Ovarian Cancer Patients
16%
Human Epididymis Protein 4
16%
Neoadjuvant Chemotherapy
16%
CA-125 Levels
16%
Ovarian Cyst
16%
Adenosine Diphosphate Ribose
16%
Epithelial Ovarian Carcinoma
16%
Polyadenosine
16%
Quantitative Sensory Testing
16%
Serum HE4
16%
Uterocutaneous Fistula
16%
Loop Electrosurgical Excision Procedure
16%
Uterine Leiomyoma
16%
Robotic Minimally Invasive Surgery
16%
Pelvic Pain
13%
Carbohydrate Antigen 125 (CA125)
12%
Conization
12%
Cervical Involvement
9%
Capital Area
8%
Two-dimensional Ultrasound
8%
Diagnostic Performance
8%
Prospective multicenter Study
8%
Preoperative Evaluation
8%
CT-MRI
8%
Cervical Invasion
8%
Lymph Node Metastasis
8%
FIGO Stage
8%
Myometrial Invasion
8%
Combination Test
8%
BRCA1 Expression
6%
Histological Grade
6%
Homologous Recombination Deficiency
6%
Evolutionary Rate
5%
Rate Matrix
5%
RNA Secondary Structure
5%
Conserved Structures
5%
MiRNA Family
5%
Structural Annotation
5%
